Vanderbilt University
Institute of Imaging Science
VUIIS Logo

Eben Rosenthal, M.D.

Professor and Chair Department of Otolaryngology?Head and Neck Surgery
Carol and John S. Odess Chair in Facial, Plastic and Reconstructive Surgery Department of Otolaryngology-Head and Neck Surgery
Professor, Department of Pathology, Microbiology and Immunology

Contact Information

e.rosenthal@vumc.org
(615) 936-0708

Interests

Dr. Eben L. Rosenthal is committed to improve survival for patients that undergo surgery for cancer. He specializes in the treatment of head and neck cancer patients and has a strong interest in the development of imaging modalities to enhance successful tumor removal in all cancer types.

Projects


Publications

Pal R, Hom ME, van den Berg NS, Lwin TM, Lee YJ, Prilutskiy A, Faquin W, Yang E, Saladi SV, Varvares MA, Rosenthal EL, Kumar ATN. First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes. Clin Cancer Res. 2022 Jun 1;28(11):2373-2384. doi: 10.1158/1078-0432.CCR-21-3429. PMID: 35302604; PMCID: PMC9167767.

Krishnan G, van den Berg NS, Nishio N, Kapoor S, Pei J, Freeman L, Lee YJ, van Keulen S, Fakurnejad S, Condon J, Back F, Martin B, Rosenthal EL. Fluorescent molecular imaging can improve intraoperative sentinel margin detection in oral squamous cell carcinoma. J Nucl Med. 2022 Jan 13:jnumed.121.262235. doi: 10.2967/jnumed.121.262235. Epub ahead of print. PMID: 35027369.

Lauwerends LJ, van Driel PBAA, Baatenburg de Jong RJ, Hardillo JAU, Koljenovic S, Puppels G, Mezzanotte L, L÷wik CWGM, Rosenthal EL, Vahrmeijer AL, Keereweer S. Real-time fluorescence imaging in intraoperative decision making for cancer surgery. Lancet Oncol. 2021 May;22(5):e186-e195. doi: 10.1016/S1470-2045(20)30600-8. Epub 2021 Mar 23. PMID: 33765422.

Lu G, Nishio N, van den Berg NS, Martin BA, Fakurnejad S, van Keulen S, Colevas AD, Thurber GM, Rosenthal EL. Co-administered antibody improves penetration of antibody-dye conjugate into human cancers with implications for antibody-drug conjugates. Nat Commun. 2020 Nov 9;11(1):5667. doi: 10.1038/s41467-020-19498-y. PMID: 33168818; PMCID: PMC7652891.

Lu G, Fakurnejad S, Martin BA, van den Berg NS, van Keulen S, Nishio N, Zhu AJ, Chirita SU, Zhou Q, Gao RW, Kong CS, Fischbein N, Penta M, Colevas AD, Rosenthal EL. Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers. Clin Cancer Res. 2020 Jun 1;26(11):2582-2594. doi: 10.1158/1078-0432.CCR-19-3717. Epub 2020 Jan 24. PMID: 31980465.